Jian Luo

8.3k total citations · 1 hit paper
133 papers, 6.3k citations indexed

About

Jian Luo is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jian Luo has authored 133 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 23 papers in Oncology and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jian Luo's work include Receptor Mechanisms and Signaling (14 papers), Bone Metabolism and Diseases (13 papers) and Neuropeptides and Animal Physiology (12 papers). Jian Luo is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Bone Metabolism and Diseases (13 papers) and Neuropeptides and Animal Physiology (12 papers). Jian Luo collaborates with scholars based in China, United States and United Kingdom. Jian Luo's co-authors include Mingyao Liu, Dali Li, Zhengfang Yi, Sung‐Gook Cho, Zhengfeng Yang, Tingfang Yi, Stefan Siwko, Daniel C.-H. Lin, Gerald M. Reaven and Jianru Xiao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jian Luo

128 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

miR‐23a‐3p‐abundant small extracellular vesicles released from Gelma/nanoclay hydrogel for cartilage regeneration

2020 240 citations Jian Luo et al. profile →

Peers

Countries citing papers authored by Jian Luo

Since Specialization

Citations

This map shows the geographic impact of Jian Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Luo more than expected).

Fields of papers citing papers by Jian Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Luo. The network helps show where Jian Luo may publish in the future.

Co-authorship network of co-authors of Jian Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Luo. A scholar is included among the top collaborators of Jian Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Luo. Jian Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sympathetic nerve inhibition enhances calvarial bone repair via senescent macrophage-induced osteogenesis and angiogenesis 2025 ·Cell Death Discovery ·Lei Zhao, (unknown), Paul Zhao, Zhiying Pang, Yu You, Chao Wu, Di Zhu, Meiling Su, Ning Zhang, Jian Luo, Yiyun Wang	0
2	Single-cell mapping reveals age-related alterations in periosteal progenitor cells and immune microenvironment 2025 ·Cell Regeneration ·(unknown), Chao Wu, Kexin Chen, (unknown), Yu You, Paul Zhao, Di Zhu, Meiling Su, Jian Luo, Yiyun Wang	0
3	Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis 2025 ·Science Advances ·Liang He, Qiansen Zhang, Yu You, Peng Sun, Ziwei Xu, Rong Li, (unknown), (unknown), Jiangnan He, Juwen Shen, (unknown), Yang Hong, Yinghua Li, Mingyao Liu, Jin‐Peng Sun, Ning Wang, (unknown), Huaiyu Yang, Jian Luo	0
4	GnIH secreted by green light exposure, regulates bone mass through the activation of Gpr147 2025 ·Bone Research ·Yu You, (unknown), Liang He, Tongyue Wang, Леи Жао, Rong Li, (unknown), (unknown), Zhiying Yue, Stefan Siwko, Ning Wang, Lujian Liao, Mingyao Liu, Jian Luo	4
5	Sorafenib inhibits ossification of the posterior longitudinal ligament by blocking LOXL2-mediated vascularization 2024 ·Bone Research ·Longqing Wang, Wenhao Jiang, (unknown), (unknown), Qing Chen, Qi Zhao, (unknown), Jian Luo, Lili Yang	8
6	The proton-activated G protein-coupled receptor GPR4 regulates the development of osteoarthritis via modulating CXCL12/CXCR7 signaling 2022 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), Liang He, Xin Niu, Yu You, Yuwei Liu, Yi Ding, Stefan Siwko, Ning Wang, (unknown), Yunyun Jin, Jian Luo	35
7	A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration 2022 ·Cell Discovery ·Yunyun Jin, Qianqian Liu, Peng Chen, Siyuan Zhao, Wenhao Jiang, (unknown), Peng Li, Yuanjin Zhang, Weiqiang Lü, Tao P. Zhong, Xinran Ma, Xin Wang, Alison Gartland, Ning Wang, Karan M. Shah, Hankun Zhang, Xu Cao, Lei Yang, Mingyao Liu, Jian Luo	29
8	Regulation of body length and bone mass by Gpr126/Adgrg6 2020 ·Science Advances ·Peng Sun, Liang He, (unknown), Zhiying Yue, Shichang Li, Yunyun Jin, Zhenxi Li, Stefan Siwko, Feng Xue, Jiacan Su, Mingyao Liu, Jian Luo	29
9	Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates 2018 ·ACS Medicinal Chemistry Letters ·Sean P. Brown, Paul J. Dransfield, Marc Vimolratana, Liusheng Zhu, Jian Luo, Jane Zhang, Xian‐Yun Jiao, Vatee Pattaropong, Simon Wong, Run Zhuang, Gayathri Swaminath, Jonathan B. Houze, Daniel C.-H. Lin	12
10	SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance 2017 ·Molecular Pharmacology ·Jing Li, Jing Ji, Yang Bai, Zhen Li, (unknown), (unknown), Xueyun Ma, Wen‐Wei Qiu, Changsheng Du, Bing Du, Fan Yang, Jie Tang, Stefan Siwko, Mingyao Liu, Huaqing Chen, Jian Luo	11
11	Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption 2016 ·Molecular Cancer Therapeutics ·Leqin Xu, Jian Luo, Rongrong Jin, Zhiying Yue, Peng Sun, Zhengfeng Yang, Xinghai Yang, Wei Wan, Jishen Zhang, Shichang Li, Mingyao Liu, Jianru Xiao	16
12	DSEP: A Tool Implementing Novel Method to Predict Side Effects of Drugs 2015 ·Journal of Computational Biology ·(unknown), Mingyuan Xin, Jian Luo, Mingyao Liu, Zhenran Jiang	13
13	GPR116, an Adhesion G-Protein–Coupled Receptor, Promotes Breast Cancer Metastasis via the Gαq-p63RhoGEF-Rho GTPase Pathway 2013 ·Cancer Research ·Xiaolong Tang, Rongrong Jin, Guojun Qu, Xiu Wang, Zhenxi Li, (unknown), Chen Zhao, Stefan Siwko, Tieliu Shi, Ping Wang, Jianru Xiao, Mingyao Liu, Jian Luo	86
14	Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents 2013 ·Molecular Cancer Therapeutics ·Heng Yang, (unknown), Jian Luo, Dawei Li, Yunfei Wang, Lisa Zhao, Stephan C. Jahn, S. Adrian Saldanha, Jamie L. Planck, Kyla Geary, Haiching Ma, Brian K. Law, William Roush, Peter Hodder, Daiqing Liao	82
15	Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway 2010 ·Carcinogenesis ·Yujuan Dong, Bojing Lu, Xiongwen Zhang, Jian Zhang, Li Lai, Dongliang Li, Yuanyuan Wu, (unknown), Jian Luo, Xuehai Pang, Zhengfang Yi, Mingyao Liu	145
16	PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53–MDM2 loop 2010 ·Nucleic Acids Research ·Weishi Yu, (unknown), Na Gao, Liren Wang, Hengxiang Cui, Yu Qian, Li Jiang, Jian Luo, Zhengfang Yi, Hua Lu, Dali Li, Mingyao Liu	36
17	A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c‐Src phosphorylation in VEGF‐induced human umbilical endothelial cells 2008 ·International Journal of Cancer ·Zhengfang Yi, Sung‐Gook Cho, Hui Zhao, Yuanyuan Wu, Jian Luo, Dali Li, Tingfang Yi, Xun Xu, Zirong Wu, Mingyao Liu	59
18	GCIP/CCNDBP1, a helix–loop–helix protein, suppresses tumorigenesis 2006 ·Journal of Cellular Biochemistry ·Wenbin Ma, Lewis J. Stafford, Dali Li, Jian Luo, (unknown), Guang Ning, Mingyao Liu	56
19	Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent 1998 ·Diabetic Medicine ·Jian Luo, Diana M. Fort, Thomas J. Carlson, (unknown), (unknown), S R King, Jeng‐Yu Tsai, (unknown), (unknown), (unknown), Nancy Waldeck, (unknown), S.D. Jolad, Donald Bierer, Gerald M. Reaven	66
20	Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata) 1998 ·European Journal of Pharmacology ·Jian Luo, (unknown), Jeanne Cheung, (unknown), Joyce Tsai, Cynthia S. Sullivan, Richard F. Hector, Michael Reed, (unknown), Steven R. King, Thomas J. Carlson, Gerald M. Reaven	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact